Form D · Other Technology
GXP CDMO BIOPHARMA LLC
Tustin, CA · CIK 0001824596
Offering snapshot reported Sep 15, 2020 · SEC filing
- Reported sold
- $250K Indefinite offering
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jan 1, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 15, 2020 | Initial | $250,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04, 06b, 04.1, 04.2, 4a5, 04.3
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-375541
Source: Form D, filed Sep 15, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ashot Petrossian | Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
14672 Canterbury Ave
Tustin, CA, 92780
Tustin, CA, 92780